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Abstract
Background: The melanocortin 1 receptor (MC1R) constitutes a key regulator of melanism. Consequently, many naturally-
occurring MC1R mutations are associated with a change in color. An example is the Glu-to-Lys substitution found at
position II:20/2.60 in the top of transmembrane helix II which has been identified in melanic mice and several other species.
This mutation induces a pronounced increase in MC1R constitutive activity suggesting a link between constitutive activity
and melanism which is corroborated by the attenuation of a-melanocyte stimulating hormone (aMSH) induced activation.
However, the mechanism by which the mutation induces constitutive activity is currently not known.
Methodology/Principal Findings: Here we characterize the constitutive activity, cell surface expression and internalization
of the mouse mutant, Mc1r E92K. As previously reported, only positively charged residues at position II:20/2.60 induced an
increase in constitutive activity as measured by cAMP accumulation and CREB activation. Furthermore, the mutation
induced a constitutive recruitment of b-arrestin. This phenomenon is only observed in MC1R, however, as the equivalent
mutations in MC2-5R had no effect on receptor signaling. Interestingly, the mutation did not induce constitutive ERK1/2
phosphorylation or increase the internalization rate indicating the constitutive activity to be biased. Finally, to identify
regions of importance for the increased constitutive activity of Mc1r E92K, we employed a chimeric approach and identified
G102 and L110 in the extracellular loop 1 to be selectively important for the constitutive activity as this, but not aMSH-
mediated activation, was abolished upon Ala substitution.
Conclusions/Significance: It is concluded that the E92K mutation induces an active conformation distinct from that induced
by aMSH and that the extracellular loop 1 is involved in maintaining this conformational state. In turn, the results suggest
that in MC1R, which lacks an extracellular loop 2, the first extracellular loop may play a more prominent role during receptor
activation than in general.
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Introduction
In mammals, melanism is regulated by the levels and
distribution of the eumelanin (black/brown) and pheomelanin
(red/yellow) pigments. The two major genetic loci involved in the
regulation of this process are extension and agouti encoding the
melanocortin 1 receptor (MC1R) and the agouti signaling protein,
respectively. MC1R is a constitutively active Gas-coupled seven
transmembrane (7TM) receptor which is expressed primarily in
epidermal melanocytes and is activated by several proopoimela-
nocortin derived peptides, most potently by a melanocyte-
stimulating hormone (aMSH). However, MC1R is unique among
7TM receptors in that it is also targeted by an endogenously
expressed inverse agonist, namely the agouti signaling protein [1].
Accordingly, both constitutive and ligand-induced activity of
MC1R can be inhibited by this peptide [2–4]. Upon MC1R
activation, accumulation of cAMP activates the rate-limiting
melanogenic enzyme tyrosinase leading to elevated and reduced
levels of eumelanin and pheomelanin, respectively. Thus,
ultimately, receptor activation results in a darker phenotype,
whereas inhibition of receptor activity results in a lighter
phenotype [1]. Structurally, MC1R and the four other melano-
cortin receptors (MC2-5R) are interesting as they possess three
unique features not found in rhodopsin-like 7TM receptors in
general. First, they lack the highly conserved cysteine residue in
the top of TM-III (CysIII:01, 90% conserved [5]) that normally
forms a functionally important disulfide bridge with a cysteine in
the extracellular loop (ECL) 2. Absence of this structural hallmark
is only found in few other receptors including the cannabinoid and
sphingosine receptors. Secondly, the ECL2 of the melanocortin
receptors (MCRs) is very short consisting of only 3 polar amino
acids keeping TM-IV and -V in close proximity of one another.
This loop is on average the longest of the three ECLs [5] and in
the currently available 7TM receptor crystal structures ECL2
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(rhodopsin [6,7]), an a-helix (b-adrenergic receptors [8,9]) or an
inter-loop disulfide bridge (adenosine A2A receptor [10]). Finally,
the ECL3 of the MCRs is unusually rich in conserved Cys and Pro
residues suggesting that it is detained in a specific fold likely by an
intra-loop disulfide bridge [11] (Figure 1A).
MC1R as well as MC3-5R have been shown to exhibit a high
level of constitutive activity i.e. signaling in the absence of an
agonist [2,11,12] which likely is physiological important. For
instance, in morbidly obese individuals several mutations in
MC4R have been identified that selectively abolish constitutive
but not ligand-induced MC4R activity [13] and still others
affecting both [14]. Given that activation of MC4R has an
anorexigenic effect, it is possible that the constitutive activity of
MC4R provides a satiety signal. In turn, when absent this could
lead to an increase in food intake and ultimately obesity. However,
even stronger evidence in favor of constitutive activity being
physiologically relevant comes from naturally-occurring mutations
in the MC1R. Thus, loss-of-function mutations in the MC1R
frequently lead to a lighter phenotype as e.g. seen in individuals
with red hair harboring the high penetrance R151C, R160W or
D294H mutations [15]. On the other hand, a range of MC1R
mutations has been identified in different species that constitutively
activate the receptor and are associated with a darker phenotype
[16–18]. Interestingly, among the latter, one specific mutation is
found in several phylogenetically distantly related species, namely
the charge-reversing Glu-to-Lys substitution at position II:20/2.60
in the top of TM-II. At the functional level, this mutation induces
a high level of constitutive activity and abolishes the activation by
aMSH [16,19]. To date, it has been identified in dominant
extension alleles associated with a melanic phenotype in the mouse
[17], several species of chicken [16,20–22], the Japanese quail
(Coturnix japonica) [23] and the Bananaquit (Coereba flaveola), a
passerine bird [24]. Furthermore, it has also been observed in
black-and-white ruffed lemurs (Varecia variegata) and red ruffed
lemurs (Varecia rubra) although in these species the mutation is not
perfectly linked to a darker coat color [25]. Although several of
these species are found in nature the mutation does not seem to
have an evolutionary advantage as such [24].
In the present study, we characterize the effect of the mouse
Glu-to-Lys MC1R substitution (E92K) on cAMP accumulation, b-
arrestin recruitment, cell surface expression, ERK activation and
Figure 1. Primary structure of the murine MC1R. A. Serpentine model of Mc1r. The highly conserved residues in each transmembrane helix of
rhodopsin-like 7TM receptors are colored in black with white letters. The putative disulfide bridge in ECL3 is indicated (-S-S-) as is the palmitoylation
site at C313. The key residues in this study, E92 at position II:20/2.60 as well as G102 and L110 in ECL1, are colored in red with white letters.
Extracellular and intracellular boundaries of the transmembrane helices were estimated using the TMHMM Server v. 2.0 (www.cbs.dtu.dk/services/
TMHMM). B. Primary structure of MC1R ECL1. Alignment of the MC1R ECL1s of the five species in which a Glu-to-Lys substitution has been identified
at position II:20/2.60 i.e. mouse (Mus musculus, accession number NP_032585), chicken (Gallus gallus brown leghorn, BAD91484), bananaquit (Coereba
flaveola, AAK50793), Japanese quail (Cortunix japonica, BAD91487) and red lemur (Varecia rubra, AAP31013). The consensus ECL1 sequence of MC1R
from 83 species is shown at the bottom. The key residues E92, G102 and L110 (mouse numbering) are highlighted in red.
doi:10.1371/journal.pone.0024644.g001
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two former. Moreover, using a chimeric approach we identify two
residues in ECL1 that are crucial for the elevated constitutive
activity of the Mc1r E92K mutant thereby suggesting a role for
ECL1 in the conformational constraining of MC1R in an active
conformation.
Results
A positive charge at position II:20/2.60 profoundly
increases Mc1r constitutive cAMP accumulation and
b-arrestin recruitment but not ERK1/2 phosphorylation
The functional impact of the naturally-occurring E92K
mutation (at position II:20/2.60, Figure 1) in the mouse MC1R
(Mc1r) was initially examined by measuring cAMP accumulation,
CREB activation (reflecting long-term changes in cAMP level) and
cell surface expression in transiently transfected HEK293 cells. In
agreement with previous findings [17,19], the E92K mutant
displayed a much higher level of constitutive cAMP accumulation
and CREB activation compared to the wt receptor (Figure 2A–B).
However, this was not due to a difference in cell surface expression
(as surface expression and constitutive activity are proportional,
[26]) since the expression levels of Mc1r wt and E92K mutant
were similar (Figure 2C). It has previously been shown that an
increase in constitutive activity only is observed when a positively
charged residue (i.e. Lys or Arg) is found at position II:20/2.60 in
Mc1r [19]. Supporting this finding, we observed a higher level of
constitutive activity for the E92R mutant but a lower for the E92A
mutant as compared to the wt receptor although their expression
was similar (Figure 2A–C).
Besides the impact of the Mc1r E92 substitutions on constitutive
activity, we also examined their effect on aMSH-induced cAMP
accumulation in transiently transfected HEK293 cells. As seen in
Figure 2D, aMSH dose-dependently activated Mc1r wt with an
EC50 value of 9.2 6 1.1 nM. However, as observed before
[16,19], aMSH was not capable of activating neither of the E92
mutants. Compared to the maximal aMSH response, the E92K
mutant was approximately 50% constitutively active whereas the
E92A mutant did not differ from pcDNA-transfected cells
(Figure 2D). To characterize this behavior further, we carried
out whole cell heterologous competition binding in transiently
transfected HEK293 cells using [
125I]NDP-MSH as radioligand.
The total specific binding of [
125I]NDP-MSH to the E92K was wt-
like whereas it was lower for the E92A mutant. To reach 10%
specific binding (of total counts) also in this case, we increased the
number of cells. For Mc1r wt, aMSH dose-dependently displaced
the radioligand with an IC50 of 2.1 6 0.1 nM (Figure 2E). On the
contrary, the affinity of aMSH for the E92A and E92K mutants
was much lower showing a .700- and 200-fold decrease in IC50
values, respectively. Thus, this demonstrates that the abolished
activation of the E92 mutants likely is a result of lack of high-
affinity ligand binding. Finally, we characterized the constitutive
and aMSH-induced recruitment of b-arrestin by Mc1R wt and
the E92 mutants in cells stably expressing a b-arrestin2-b-
galactosidase fusion protein. b-arrestin was dose-dependently
recruited by aMSH in cells transiently transfected with a Mc1r
wt-b-gal fusion constructs with an EC50 of 1.0 6 0.3 nM
(Figure 2F) which is in good agreement with the cAMP
accumulation EC50 value (Figure 2D). Contrary to the wt receptor,
aMSH did not recruit b-arrestin in cells transfected with any of the
E92 mutants also in agreement with the cAMP accumulation and
binding results (Figure 2D-E). However, b-arrestin was also
recruited constitutively (i.e. in the absence of aMSH). Of note, this
recruitment was much more profound for the E92K mutation
than Mc1r wt or the E92A mutant thus reflecting the activity
profile observed in both the cAMP accumulation and CREB
activity assays. Although the activity of the E92A mutant tended to
be lower than wt in these assays, no difference in b-arrestin
recruitment was observed.
It has previously been demonstrated that agonist-induced
activation of the human MC1R leads to phosphorylation and
activation of the extracellular signal regulated kinases (ERK) 1 and
2 [27]. To examine whether this also applies to the murine
ortholog and E92 mutants, we measured ERK1/2 activation in
transiently transfected HEK293 cells. As seen in Figure 3A,
aMSH dose-dependently activated ERK1/2 in cells expressing
Mc1r wt with an EC50 of 3.7 6 0.5 nM. Furthermore, we also
examined the kinetics of the phosphorylation and found this to
peak at 10 min after exposure to aMSH (Figure 3B). Contrary to
the wt receptor, aMSH was not able to activate ERK1/2 in cells
expressing the E92A or the E92K mutants in agreement with the
binding experiments although a low response was observed for the
E92K mutant at a aMSH concentration of 1 mM. Of note, despite
being highly constitutively active with regard to cAMP accumu-
lation (Figure 2), the E92K mutant did not display any constitutive
ERK activation indicating biased activation with regard to
constitutive activity.
A positive charge at position II:20/2.60 does not
constitutively activate MC2-5R
The five melanocortin receptors (MC1-5R) are up to 45%
identical at the protein level. Several residues are conserved
among the five members including the Glu at II:20/2.60. To
examine whether the same phenomenon applied for the four other
melanocortin receptors, we substituted Glu for Arg or Ala in the
human MC2-5R and measured the constitutive cAMP accumu-
lation including human MC1R as control. As observed for Mc1r, a
Glu-to-Arg substitution at position II:20/2.60 in the human
MC1R induced an increase in constitutive activity compared to
the wt receptor (1.4-fold at 15 ng DNA/well) whereas the Ala
substitution did not (Figure 4A, table 1). Contrary to MC1R, none
of the other MCR wt receptors were constitutively active although
this has been reported for MC4R previously [28]. However, we
did not observe any constitutive activity of this receptor in the
CREB assay either or for Mc4r (data not shown). In addition, no
increases in activity were observed when an Arg was introduced at
II:20/2.60 in MC2-5R (Figure 4B-E, Table 1). For MC5R, the
Ala substitution induced an increase in cAMP accumulation (1.2-
fold, Figure 4E), however, given this was not observed for the Arg
substitution it is likely an unrelated mechanism. In all cases, the wt
and mutant constructs were expressed well at the surface (. 2-fold
over basal). This was also the case for MC2R although we did not
co-express MRAP. Thus, MC1R is the only of the MCRs in which
a positive charge at II:20 induces constitutive activity.
Constitutive and ligand-induced internalization of Mc1r
wt and E92K mutant
We next examined the effect of the E92K substitution on
receptor internalization using two methods. First, we employed an
anti-body feeding approach in which cell surface expressed
receptors were labeled with primary antibody followed by
incubation with either PBS to assess constitutive internalization
or aMSH to examine ligand-induced internalization. Subsequent-
ly, labeled receptors still residing at the surface and those
internalized were separately detected using two different fluor-
ophore-conjugated secondary antibodies before (Figure 5A-B, left
panels) and after permeabilisation (middle panels), respectively.
Novel Roles of the MC1R E92K Mutation
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ELISA-based assay (Figure 5C). As seen Figure 5A and 5B, both
Mc1r wt and the E92K mutant were constitutively internalized as
labeled receptors were present in endosomes after 30 min
incubation with PBS only (red channel, top rows Figure 5A–B).
However, a significant part of the labeled receptor pool still resided
on the surface (green channel) suggesting the internalization rate to
be modest. Accordingly, in both cases only 25% of the receptors
were constitutively internalized during incubation as measured by
ELISA (Figure 5C). It is interesting to note that despite its high
constitutive activity and b-arrestin recruitment, the E92K mutant
did not internalize faster than the wt receptor suggesting biased
activity like that observed for ERK1/2 phosphorylation. As
expected, incubation with aMSH resulted in a prominent
internalization of Mc1r wt with only 30% of the receptors still
residing at the cell surface after 30 min (Figure 5A bottom row and
5C). On the contrary, aMSH did not induce internalization of
Mc1r E92K (Figure 5B bottom row and 5C) which aligns well with
the previous notion that aMSH does not activate this mutant.
Although recycling of tagged receptors may influence the
measurement of internalization, we estimated the extent of
recycling within the 30 min incubation period to be 5%. Thus,
the contribution of recycling in these assays is minimal.
ECL1 is involved in the increased level of Mc1r E92K
constitutive activity
As an increase in the constitutive activity of MC1R only is
observed when a positively charged residue is present at position
II:20/2.60(Figure 2 and [19]),ithaspreviouslybeen speculatedthat
the Lys of Mc1r E92K interacts witha negatively chargedresidue in
the vicinity favoring a more active conformation [19]. However, in
the same study, Ala substitution of all negatively charged residues
near II:20/2.60 did not abolish the increase in activity suggesting
the interaction to be of a different nature. To examine this further
we exploited that the corresponding Glu-to-Lys substitution at
position II:20/2.60 in Mc4r does not induce constitutive activity
(Figure 3). Initially, we analyzed the extracellular subdomains as
they are highly divergent between these receptors. To do so we
constructed chimeric receptors by swapping the N-terminus, ECL1
and ECL3 of Mc1r with the corresponding Mc4r subdomains. An
ECL2 chimera was not generated as this loop consists of only 3
amino acids in the melanocortin receptors (Figure 1). Each swap
Figure 2. A positive charge at position II:20/2.60 increases the level of MC1R constitutive cAMP accumulation, CREB activity and b-
arrestin recruitment. A. cAMP accumulation in HEK293 cells transiently transfected with FLAG-tagged Mc1r wt (solid squares), Mc1r E92K (open
squares), Mc1r E92R (open triangle), Mc1r E92A (solid circle) or pcDNA (open circles) at 0, 5, 15 or 25 ng DNA per well. The results represent mean 6
SEM of raw data from four independent experiments performed in triplicates. B. CREB activity reflecting long-term changes in cAMP levels measured
in HEK293 cells transiently transfected with CREB-LUC reporter vector and FLAG-tagged Mc1r wt (solid squares), Mc1r E92K (open squares), Mc1r E92R
(open triangle), Mc1r E92A (solid circle) or pcDNA (open circles) at 0, 5, 15 or 25 ng DNA per well. The results are normalized to the basal activity (i.e.
at 0 ng DNA/well) and represent mean 6 SEM of four independent experiments performed in quadruples. C. Cell surface expression of the same
constructs as in A and B. The results are performed and presented the same way as in A. D. aMSH-induced activation as measured by cAMP
accumulation n HEK293 cells transiently transfected with FLAG-tagged Mc1r wt (solid squares), Mc1r E92K (open squares), Mc1r E92A (solid circle) or
pcDNA (open circles) at 25 ng DNA per well. The results are normalized to background (0%, pcDNA in the absence of aMSH) and the maximal level of
agonist-induced stimulation (100%, Mc1r wt at [aMSH] = 1 mM) and represent mean 6 SEM of at least three independent experiments performed in
triplicates. E. Heterologous competition binding in HEK293 cells transiently transfected with Mc1r wt (solid squares), Mc1r E92K (open squares) or
Mc1r E92A (solid circle) at 50 ng DNA/well using [
125I]-NDP-MSH as radioligand (60 pM). The results have been corrected for non-specific binding (i.e.
binding to pcDNA-transfected cells in presence of 1 mM aMSH) and are presented relative to the binding in absence of aMSH in percent as mean 6
SEM of three independent experiments. F. aMSH-induced b-arrestin recruitment in CHO cells stably expressing a b-arrestin-b-galactosidase fusion
construct. The cells were transiently transfected with Mc1r wt-b-gal fusion construct (solid squares), Mc1r E92K construct (open squares), Mc1r E92A
construct (solid circle) or vector control (open circles) at 50 ng DNA/well and exposed to increasing concentrations of aMSH. The results are given in
percent relative to the maximal aMSH-induced response of Mc1r wt and are mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0024644.g002
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expression and constitutive activity evaluated using ELISA and
CREB reporter assays, respectively. We normalized the CREB
activity to the expression level (measured at 2.5 ng DNA/well) as
these are proportional (Figure S1) to obtain the so-called relative
constitutive activity (RCA).
All chimeras were expressed well at the surface and their
expression levels comparable to that of Mc1r wt (Figure 6A). As
expected, the CREB activity of the E92K mutant was much higher
than the wt receptor whereas the cell surface expression level was
similar. Accordingly, the RCA value of the E92K mutant was
higher being increased 1.5 fold (Figure 6A, Table 2). This was also
observed for the N-terminus and the ECL3 chimeras where the
RCA values of the E92K constructs were 1.5 and 3.0 fold higher
than the corresponding wt constructs, respectively (Figure 6B and
D, Table 2) indicating that none of these regions are important for
the increased constitutive activity induced by the E92K mutation.
On the contrary, in the case of ECL1, the RCA value of the E92K
construct was 1.5 fold lower (Figure 6C, Table 2). To examine
whether this also extends to the human MC1R we generated the
equivalent ECL1 constructs in this receptor. Similarly, the RCA
value of the corresponding E94K construct was 1.2 lower than the
wt construct (Figure S2). To consolidate this finding further, we
designed a construct (DECL1) in which the ECL1 of Mc1r was
replaced by 6 Ala residues. As shown in Figure 6E, both the wt
and E92K DECL1 constructs were expressed well at the surface
although at lower levels than the chimeras. Notably, whereas the
cell surface expression of the E92K construct was higher than the
wt counterpart, the CREB activity was equivalent to wt resulting
in a statistically significant decrease in RCA of 1.4 fold (Figure 6E,
Table 2). It should be noted that the domain swapping results in
large changes in the RCA values. For the ECL1 and DECL1
constructs, the RCA is increased suggesting that ECL1 contains
structural elements that stabilize Mc1r in a low activity
conformation (Figure 6, Table 2). On the contrary, the RCA of
the ECL3 constructs are decreased suggesting this loop to have an
opposite function. Collectively, the chimera data indicate that the
ECL1 of Mc1r harbors one or more residues essential to the
increased constitutive activity of the E92K mutant.
ECL1 residues G102 and L110 are essential to the
increased level of Mc1r E92K constitutive activity
To determine whether this is the case, we swapped the ECL1
residues individually. Initially, we examined the ECL1 sequences of
Mc1r and Mc4r to determine the degree of conservation. As shown
in Figure 7A, only 6 residues (I96, L98, L99, A106, V111 and L114
in Mc1r) are identical or functionally conserved. Initially, we
generated 5 double mutations replacing two non-conserved
consecutive residues of the Mc1r ECL1 with the corresponding
Mc4r residues at a time. All constructs were well expressed at the
surface(80–140%ofMc1r wt,Table 2).The E92K constructsof the
three mutants E100N-V101S, L104T-V105D and R107Q-V108S
Figure 3. Mc1r-mediated ERK1/2 phosphorylation. A. aMSH-induced ERK1/2 phosphorylation in HEK293 cells transiently transfected with Mc1r
wt (solid squares), Mc1r E92K (open squares) or Mc1r E92A (solid circles, lower). The data are presented relative to the Mc1r wt receptor-mediated
phosphorylation in absence of aMSH indicated as [aMSH]=0 and are mean 6 SEM of three independent experiments. The lower panels show
representative blots of phosphorylated ERK1/2 (pERK) and total ERK (tERK) detected on the same membrane. The phosphorylation was measured
after 10 min incubation in presence of aMSH. B. Kinetic analysis of aMSH-mediated ERK1/2 phosphorylation in HEK293 cells transiently transfected
with Mc1r wt. The phosphorylation was measured after 5, 10 and 15 min of incubation. The quantitative data shows the phospho-ERK : total ERK ratio
at different aMSH concentrations (indicated as the power of 10) and are mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0024644.g003
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PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24644Figure 4. Impact of a positive charge at position II:20 in human MC1-5R. A–E. cAMP (left column) and cell surface expression (right column)
in HEK293 cells transiently transfected with FLAG-tagged human MC1R (A), MC2R (B), MC3R (C), MC4R (D) or MC5R (E) wt receptor (solid squares), Glu-
to-Ala (solid circles), Glu-to-Arg (open triangles) mutants or pcDNA (open circles) at 0, 5, 15 or 25 ng DNA per well. The results are given relative to the
background level in the absence of receptor (i.e. at 0 ng/well) as mean 6 SEM of at least three independent experiments performed in quadruples.
doi:10.1371/journal.pone.0024644.g004
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to their wt counterparts thus being functionally similar to Mc1r wt
and the E92K mutant (Figure 7B, Table 2). On the contrary, for the
G102T-I103D and A109F-L110T mutants we found no statistically
significant difference between the RCA values of the wt and E92K
constructs (Figure 7B, Table 2). Consequently, the mutants G102T,
I103D and L110T were generated to address which residues were
important. We did not include the A109 residue as it is not
conserved among those species in which a Glu to Lys substitution at
position II:20/2.60 has been found (Figure 1B). As seen in
Figure 7C, the E92K constructs of the G102T and L110T mutants
displayed a significant decrease in RCA values compared to the wt
counterparts (1.6 and 1.4 fold, respectively), whereas an increase
was observed for I103D (1.3 fold). The decreases observed for these
mutants were not merely a result of introduction of Mc4r residues as
the wt and E92K RCA values of the corresponding G102A and
L110A constructs were similar and even significantly lower (1.5 fold
decrease) for the G102A-L110A mutant (Figure 7D, Table 2). Of
note, the RCA values of the Mc1r wt and the ECL1 mutants were
largelysimilarandnotincreasedasobservedfortheECL1swapand
the DECL1 constructs. Thus, collectively, these results indicate that
the increase in constitutive activity induced by E92K in Mc1r is
specifically dependent on G102 and L110. However, G102 and
L110 seem to be important for the constitutive activity only as all
mutants were activated with approximately the same potency as
Mc1r wt (Figure 7D, inset). Of note, these residues are conserved in
all five species in which the Glu-to-Lys substitution has been
identified; Gly is fully conserved and the Leu functionally conserved
(being Leu, Ile or Val) (Figure 1B) thus further indicating that they
are of functional importance.
Discussion
The II:20/2.60 Glu-to-Lys substitution in MC1R is highly
interesting both from a genetic and a structural perspective. First,
it has been identified in the dominant extension alleles in five Table 1. Impact of position II:20/2.60 in the MCR family.
Rec./Var. cAMP (n) ELISA (n)
MC1R wt 261 6 51 3 205 6 11 4
E94A 236 6 87 3 249 6 25 4
E94R 437 6 103 3 288 6 31 4
MC2R wt 91 6 9.7 3 282 6 46 4
E80A 92 6 3.4 3 156 6 34 4
E80R 93 6 0.6 3 226 6 44 4
MC3R wt 93 6 1.8 3 562 6 146 6
E94A 93 6 2.2 3 437 6 45 6
E94R 92 6 2.5 3 605 6 52 6
MC4R wt 97 6 5.3 3 466 6 72 3
E100A 92 6 5.6 3 608 6 31 3
E100R 89 6 1.8 3 598 6 20 3
MC5R wt 91 6 3.1 3 437 6 32 5
E92A 116 6 4.8 3 417 6 38 5
E92R 91 6 6.0 3 444 6 29 5
Constitutive cAMP accumulation and cell surface expression (ELISA) of the
human melanocortin wt receptors (MC1-5R) and II:20/2.60 mutants (Ala and
Arg) measured in HEK293 cells transiently transfected with 15 ng DNA/well.
The results are given relative to the background level in the absence of receptor
(i.e. at 0 ng DNA/well) as mean 6 SEM. Rec./Var.: Receptor/Variant.
doi:10.1371/journal.pone.0024644.t001
Figure 5. Effect of the E92K mutation on receptor internaliza-
tion. Antibody-feeding internalization assay. Internalization of FLAG-
tagged Mc1r wt (A) or Mc1r E92K (B) in transiently transfected HEK-g
cells (150 ng DNA per well) in the presence of vehicle (PBS, upper rows)
or aMSH at 1 mM (lower rows). Receptors at the surface were labeled
with M1 anti-FLAG antibody prior to an internalization period of 30 min
at 37uC. Subsequent to this, labeled receptors still residing at the cell
surface were detected before cell permeabilisation (green, left) and
internalized receptors after (red, middle) with two different fluoro-
phore-conjugated secondary antibodies (Alexa Fluor 488 and 568,
respectively) and analyzed by confocal microscopy. Merged images are
presented to the right. Images are representative of two independent
experiments. Mock cells were used as controls for unspecific binding of
primary or secondary antibodies of which none was seen. Scalebars
represent 10 mm. C. ELISA-based internalization assay. Cell surface
expression in HEK-g cells transiently transfected with FLAG-tagged Mc1r
wt or Mc1r E92K at 25 ng DNA per well either before (t=0’) or after
(t=309) an internalization period of 30 min at 37uC in the presence of
vehicle (PBS, left) or aMSH at 1 mM (right) as measured by ELISA. The
results are given relative to the cell surface expression of Mc1r wt in the
absence of ligand (PBS) before internalization (t=09) as mean 6 SEM of
four independent experiments performed in quadruples. ** p,0.01; ns,
not significant.
doi:10.1371/journal.pone.0024644.g005
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24644Figure 6. ECL1 is important for the increased constitutive activity of Mc1r E92K. A–E. Cell surface expression (left column) and CREB
activity (middle column) as measured using ELISA and the CREB reporter assays, respectively, in HEK293 cells transiently transfected with wt (solid
squares) or E92K (open squares) FLAG-tagged Mc1r-Mc4r chimeric constructs at 0, 1, 2.5 and 5 ng DNA per well. (A) Mc1r wt and Mc1r E92K, (B) wt
and E92K N-terminal chimeras, (C) wt and E92K ECL1 chimeras, (D) wt and E92K ECL3 chimeras and (E) wt and E92K DECL1 constructs. In A–D, the
serpentine inserts in the left column illustrate which segment of Mc1r (white) has been replaced by the corresponding Mc4r sequence (black). In E,
the black segment illustrates the 6 Ala replacing ECL1. The position of E92 in TM-II is also marked in black in all cases. The results has been corrected
for background (pcDNA-transfected cells) and are given relative to the Mc1r wt level 2.5 ng DNA/well in percent as mean 6 SEM of at least three
independent experiments performed in quadruples. The relative constitutive activity (RCA, right column) is calculated for the 2.5 ng DNA per well
gene-dose as described in Materials and methods and given relative to the RCA of Mc1r wt in percent as mean 6 SEM. wt and E92K constructs are
depicted in black and white columns, respectively. ** p , 0.01 and *** p , 0.001 by Student’s t-test.
doi:10.1371/journal.pone.0024644.g006
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most frequent interspecies mutations in the 7TM receptor
superfamily. Second, in all but one (red lemur), the presence of
this mutation is associated with a melanic phenotype. Given that
the II:20/2.60 mutation has been shown to significantly increase
the constitutive activity of both murine (Figure 2 and [17,19]) and
chick [16] MC1R, it is tempting to speculate that the increased
level of constitutive activity is the primary cause of melanism in
species containing this mutation. This hypothesis is further
consolidated by the notion that the ligand-induced activation by
the endogenous agonist aMSH is abolished [29]. Also, in several
species, constitutively activating mutations have been identified in
other MC1R residues which likewise are linked to a darker
phenotype. These include the melanic C123R and D121N
substitutions found in the Alaska silver fox [18] and sheep or pigs
[30,31], respectively (Figure 8A). Interestingly, these and other
activating mutations tend to cluster in the region around TM-II,
ECL1 and TM-III in a variety of species and are in general found
on the same helix face predominantly facing towards the binding
pocket (Figure 8A). Moreover, deletions of TM-II (including II:20/
2.60) or ECL1 residues have been identified in the melanic
variants of the gray squirrel [32], rabbit [33], Jaguar and
Jaguarundis [34]. Although, these MC1R deletions have not been
pharmacologically characterized it has been speculated that they
either exhibit an elevated level of constitutive activity compared to
their wt counterparts or are hyperactive i.e. elicit an amplified
agonist-induced response [32]. In favor of the former possibility,
the constitutive activity (i.e. RCA) of the Mc1r DECL1 construct
(which lacks ECL1) was elevated approximately 4.5-fold compared
to the Mc1r wt (Figure 6A and E, right panels) but could not be
activated by aMSH (data not shown). Of note, we have previously
generated similar DECL1 constructs in EBI2 and GPR17 (both
constitutively active [35,36]) among others. However, in all cases,
removal of ECL1 has been deleterious (unpublished data). In turn,
this indicates that the unique absence of the conserved disulfide
bridge between TM-III and ECL2 and/or the very short ECL2 of
MC1R allows a high degree of structural flexibility in the region
around TM-II and -III which putatively could account for the
high mutation rate observed in this area.
In the present study, we identified two ECL1 residues, G102
and L110, which are essential for the increased constitutive activity
induced by the E92K mutation. Thus, in both cases, the
constitutive activity of the E92K construct was either equal to
(Ala substitution) or even lower (Thr substitution) than the
corresponding wt construct (Figure 7). Importantly, these residues
are selectively important for the constitutive activity of E92K as the
agonist-induced activation by aMSH is not affected by Ala-
substitution (Figure 7, insets). Interestingly, a dominant G104S
mutation at the equivalent position to G102 has recently been
identified in MC1R of the water buffalo [37]. This mutation was
perfectly associated with a black coat color and although not
pharmacologically characterized it was estimated to be of
functional importance by in silico analysis. The same G104S
mutation has also been found in humans although the functional
impact is unclear [38]. Moreover, in the melanic variants of rock
pocket mice, one of four MC1R mutations associated with this
phenotype is found in ECL1 (a R109W substitution). Finally, in
the rabbit, the entire ECL1 has been deleted in one of the
pheomelanic MC1R alleles [33]. Thus, collectively, these results
suggest that the ECL1 of MC1R indeed is of importance and, in
some cases, associated with melanism. This is also indicated by the
notion that the ECL1 in MC1R is much longer than that of an
average family A 7TM receptor whereas ECL3 is of normal length
[5]. In general, ECL2 is the loop of greatest functional importance
in the family A [39]. However, given this consists of only 3 amino
acids in MC1R, it can be speculated that ECL1 might functionally
substitute for ECL2 in this receptor. Moreover, besides MC1R,
ECL1 has been shown to be important for ligand binding and
receptor activation in several other receptors including the C5a
[40], Ste2p [41], neurotensin receptor 1 [42], M4 muscarinic
receptor [43] and angiotensin II receptor [44] thus pointing to that
not only ECL2 is of functional importance for receptor activation.
In addition, several mutations in ECL1 of the MC4R have been
linked to obesity including a Thr-to-Met substitution (residue 112)
Table 2. Importance of ECL1 for the constitutive activation of
the E92K mutant.
Construct CREB ELISA RCA DRCA (n)
Mc1r wt 100 60.0 100 60.0 100 60.0 1 9
E92K 159 66.9 109 65.6 148 68.2 1.5 9
Chimeras N-terminal wt 213 629 160 624 134 66.3 4
E92K 317 67.2 152 616 208 613 1.5 4
ECL1 wt 213 614 63 65.8 353 629 9
E92K 223 616 95 65.8 241 622 0.7 9
ECL3 wt 33 63.1 92 67.6 36 643
E92K 96 613 88 65.7 109 617 3.0 3
DECL1 wt 271 614 61 66.5 469 651 4
E92K 299 626 84 67.2 380 621 0.7 4
Double
mutants
E100N-V101S wt 96 66.9 110 67.9 88 67.0 4
E92K 155 612 113 66.9 139 614 1.6 4
G102T-I103D wt 127 68.9 117 67.2 110 612 5
E92K 162 69.2 144 65.6 113 68.3 1.0 5
L104T-V105D wt 85 67.4 137 614 64 69.0 3
E92K 259 611 172 614 151 611 2.4 3
R107Q-V108S wt 84 67.7 129 65.8 65 65.5 5
E92K 158 614 150 64.3 107 613 1.7 5
A109F-L110T wt 127 624 69 66.5 184 641 3
E92K 177 611 156 611 116 612 0.6 3
G102A-L110A wt 130 616 74 616 177 612 3
E92K 116 618 97 69.3 119 615 0.6 3
Single
mutants
G102T wt 79 63.3 44 66.4 190 626 4
E92K 148 69.9 131 616 116 68.3 0.6 4
G102A wt 34 612 27 67.1 124 612 3
E92K 173 625 164 655 104 612 0.8 3
I103D wt 94 63.6 112 67.9 85 65.3 4
E92K 169 69.3 158 615 109 67.3 1.3 4
L110T wt 143 612 103 68.5 141 612 4
E92K 155 614 158 65.1 99 611 0.7 4
L110A wt 152 650 120 616 110 624 4
E92K 353 6161 200 659 163 624 1.5 4
Constitutive CREB activity and cell surface expression (ELISA) of wt and E92K
Mc1r-Mc4r chimeras and ECL1 mutants in transiently transfected HEK293 cells.
CREB activity and ELISA data are normalized to the Mc1r wt level at 2.5 ng DNA/
well and given in percent as mean 6 SEM. The relative constitutive activity
(RCA) is calculated by normalizing the CREB activity to the cell surface
expression at 2.5 ng DNA/well as described in Materials and Methods and is
given relative to the RCA of Mc1r wt. The fold change between the RCA values
of the wt and E92K constructs on a given background is presented as DRCA.
doi:10.1371/journal.pone.0024644.t002
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receptor [45] and an insertion of an extra adenine resulting in loss
of function [46]. Finally, the ECL1 of the thyroid-stimulating
hormone receptor (TSHR) is crucial for receptor activation
possibly by interacting with the ectodomain [47]. Of note, several
ECL1 mutations that alter TSHR constitutive activity have been
Figure 7. G102 and L110 are essential for the increased constitutive activity of Mc1r E92K but not agonist-induced activation. A.
Alignment of the Mc1r and Mc4r ECL1 sequences. The stapled box encircles those residues that are not conserved between the two receptors. B. RCA
values of wt (black columns) and E92K (white) constructs of Mc1r-Mc4r double-swap mutations as well as Mc1r (positive control) and ECL1 chimeras
(negative control) at a gene-dose of 2.5 ng DNA per well in transiently transfected HEK293 cells. The results are given relative to the RCA of Mc1r wt
in percent as mean 6 SEM of at least four independent experiments performed in quadruples. C. RCA values of wt and E92K constructs of Mc1r-Mc4r
single-swap G102T, I103D and L110T mutations. Performed and presented as in B. inset. aMSH-induced activation as measured by CREB activity in
HEK293 cells transiently transfected with Mc1r wt (stapled line), G102T (solid circles), L110T (open circles) or pcDNA (open squares) at 25 ng DNA per
well. The results are normalized to background (0%, pcDNA in the absence of aMSH) and the maximal level of agonist-induced stimulation (100%,
Mc1r wt at [aMSH] = 1 mM) and represent mean 6 SEM of three independent experiments performed in quadruples. D. RCA values of wt and E92K
constructs of the G102A, L110A and G102A-L110A mutations. Performed and presented as in B. inset. aMSH-induced activation as measured by CREB
activity in HEK293 cells transiently transfected with Mc1r wt (stapled line), G102A (solid circles), L110A (open circles) or pcDNA (open squares) at
25 ng DNA per well. The results are normalized to background (0%, pcDNA in the absence of aMSH) and the maximal level of agonist-induced
stimulation (100%, Mc1r wt at [aMSH] = 1 mM) and represent mean 6 SEM of three independent experiments performed in quadruples. * p , 0.05,
** p , 0.01, *** p , 0.001 and ns, not significant.
doi:10.1371/journal.pone.0024644.g007
Figure 8. Model of MC1R. A. TM-II and -III viewed from within the receptor showing the positions that have been found to be associated with
melanism in different species (in grey). The species and type of mutation are presented with the numbering following that of the given species. As in
A, the key residues of this study are shown in yellow. B. Model of MC1R generated using TASSER [52] as viewed from the extracellular side. TM-II and -
III are colored in blue, whereas TM-IV and -V are grey. The equivalent MC1R amino acids to the key residues of this study are colored in yellow being
E94 (E92 in the mouse), G104 (G102) and V112 (L110).
doi:10.1371/journal.pone.0024644.g008
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[48] or hyperthyroidism (gain-of-function) [49] emphasizing the
importance of ECL1 in in vivo settings.
It is interesting to note that the E92K mutation only induces
constitutive activation of Gas and b-arrestin recruitment (Figure 2)
but does not constitutively activate ERK1/2 (Figure 3) or result in
a higher constitutive internalization rate (Figure 5). This is also the
case for the constitutive activity of the Mc1R wt and thus indicates
that the conformational state of constitutive activity is distinct from
that stabilized by the agonist. Alternatively, this difference in
activation may be explained by the fact that constitutive
conformational states tend to be rather transient whereas
agonist-induced states are more stable which could influence
interaction with effector proteins [50]. In both scenarios, this could
result in differences in e.g. receptor phosphorylation and scaffold
protein binding that are important for effector protein activation.
Thus, our results collectively indicate that the E92K mutation
activates the receptor in a biased mode with regard to the
constitutive activity. Of note, biased agonist-induced activation has
recently been reported for MC4R. Thus, as showed by Bu ¨ch et al,
MC4R not only couples to Gas but also Gai in a hypothalamic
cell line [51]. Interestingly, the endogenously expressed Gas
antagonist agouti-related protein was shown to be a Gai agonist
thus activating MC4R in a biased mode.
As an elevated level of MC1R constitutive activity is only
achieved when a positively charged residue is present at position
II:20/2.60 (Figure 2) this suggests that E92K participates in a
functionally important electrostatic interaction. Given the chem-
ical properties of G102 and L110 it is clear that these residues,
although important, play an indirect role. Thus, the interaction
partner(s) and mechanism of the E92K substitution still remain to
be identified. In a previous study, a comprehensive mutational
analysis was carried out to address this question [19]. However,
although all negatively charged residues in the vicinity of E92K
were substituted with Ala, this did not reduce the level of
constitutive activity. Interestingly, we have recently reported the
same phenomenon in the orphan 7TM receptor EBI2 [26]. Thus,
in this receptor an Arg is found at position II:20/2.60 (R87). This
residue was shown to be crucial for the constitutive activity as
substitution to anything but Lys completely abolished the activity.
Thus, analogously to MC1R, a positively charged residue at
position II:20/2.60 is required for constitutive activation. Howev-
er, although we targeted all negatively charged residues in the
vicinity of R87, none of these were functionally important.
Collectively, these results suggest that in both EBI2 and Mc1r
E92K the intramolecular interaction partner(s) of the II:20/2.60
residue, if any, are not negatively charged. One possibility is that
the II:20/2.60 residue participates in a cation-pi interaction with
one or more unidentified aromatic residues instead. Yet another
possibility is that the positively charged II:20/2.60 residue in EBI2
or Mc1r E92K interacts with the negatively charged phosphohead
groups of the surrounding lipid bilayer. As seen in the TASSER
model of MC1R (Figure 8B) [52] and the current 7TM receptor
crystal structures [7–10], the residue at position II:20/2.60 is
partly facing the lipid environment and partly TM-III depending
on the side chain conformation. Thus, given the orientation of
II:20/2.60 it is positioned well to interact with phosphohead
groups in the vicinity. Although never shown for 7TM receptors, it
has recently been demonstrated that a similar interaction exists in
voltage-dependent ion channels [53–56]. These channels open
and close in response to motion of the S4 voltage sensors, which
consists of a-helices harboring four or more highly conserved
positively charged residues [55,56]. For instance, by reconstituting
purified KvAP, a voltage-dependent K+ channel, into bilayers of
different lipid composition it was demonstrated that the presence
of lipids containing a negatively charged phosphodiester group was
essential for the function of the channel [53]. Future experiments
will have to determine whether this also could be the case for 7TM
receptors such as EBI2 and the E92K Mc1r mutant. In
conclusion, the present study adds to our knowledge about the
naturally-occurring Glu-to-Lys substitution at position II:20/2.60
showing that (i) it induces an active conformational state distinct
from the agonist-induced and (ii) that this state is highly dependent
on ECL1. In turn, these results also substantiate that MC1R
indeed possesses unique structural features not found in the
majority of 7TM receptor family which likely allow for the high
mutation rate observed for this receptor and often results in
dramatic phenotype changes.
Materials and Methods
Materials
The murine and human MC1Rs (accession numbers
NM_008559 and NM_002386) and MC4Rs (NM_016977 and
NM_005912) were kindly provided by Birgitte Holst (Laboratory
for Molecular Pharmacology, University of Copenhagen, Den-
mark). Human MC2R (NM_000529), MC3R (AY227893) and
MC5R (NM_005913) were purchased from Missouri S&T cDNA
Resource Center (www.cDNA.org). Lipofectamine
TM 2000 trans-
fection reagent and OPTIMEM were purchased from Life
Technologies. SteadyLite (Lyophilized Substrate Solution) was
from Packard (Boston, MA). Goat anti-mouse horseradish
peroxidase-conjugated antibody was from Pierce (Rockford, IL),
while mouse anti-M1-FLAG antibody, forskolin and pertussis
toxin were from Sigma Chemicals Co. (St. Louis, MO). Both the
SlowFade Antifade reagent, goat anti-mouse Alexa Fluor 488-
conjugated and Alexa Flour 568-conjugated antibodies were from
Molecular Probes (Carlsbad, CA). The TMB (3,39,5,59-tetra-
methylbenzidine) substrate was purchased from KemEnTech
(Taastrup, Denmark). aMSH was from Bachem (Torrance, CA,
USA).
Site-directed mutagenesis
All constructs were inserted into a modified pcDNA3 vector,
kindly provided by Kate Hansen (7TM-Pharma, Denmark), which
contained an upstream sequence encoding a hemagglutinin signal
peptide fused to the M1-FLAG tag. Site-directed mutagenesis was
carried out using the Pfu polymerase (Stratagene) and the
generated mutations were verified by DNA sequencing (MWG
Biotech, Martinsried, Germany).
Transfection and tissue culture
HEK293 cells were grown in DMEM (Invitrogen) adjusted to
contain 4500 mg/L glucose, 10% FBS (fetal bovine serum),
180 u/ml penicillin and 45 mg/mL streptomycin (PenStrep) at
10% CO2 and 37uC. HEK-g cells (HEK293 cells stably
transfected with the macrophage scavenger receptor) were grown
in the same medium but with Zeocin (Invitrogen) added at 200
mg/mL. For CREB-luciferase and ELISA assays, transient
transfections were carried out using Lipofectamine
TM 2000
reagent and the serum-free medium OPTIMEM as described in
[26]. Cells were always transfected in parallel for the CREB
luciferase and ELISA assays. The CHO-K1 EA-arrestin parental
cell line stably expressing b-arrestin fused with b-gal inactive form
(DiscoveRx) was cultured in F-12 HAM medium supplemented
with 10% FBS, PenStrep and 250 mg/ml Hygromycin B
(Invitrogen). Cells were transfected with DNA using FuGENE6
transfection reagent (Roche Diagnostics) according to manufac-
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transfected using the calcium phosphate precipitation method.
cAMP assay
Levels of cAMP were measured using the HitHunter cAMP XS+
kit according to the manufacturer’s recommendations (DiscoveRx,
Fremont, CA, USA). HEK293 cells were seeded at 20,000 cells/well
in 96-well plates and transiently transfected the following day with
FLAG-tagged receptor constructs or pcDNA at the indicated
concentrations. Twenty-four hours later, cells were washed twice
with HBS buffer (20 mM HEPES, 150 mM NaCl, pH 7.4) and
incubated 30 min at 37uC in HBS containing 1 mM IBMX
phosphodiesterase inhibitor (Sigma). If used, ligands were then added
followed by a 25 min incubation at 37uC. Subsequently, antibody
reagent and lysis solutions were added and the plates incubated 1 h
on a shaker. Finally, enzyme solution was added and the plates
incubated by over-night incubation on a shaker. The luminescence
was subsequently measured using a TopCounter (Packard).
CREB trans-reporter luciferase assay
The trans-reporter CREB-luciferase assay was used to measure
long-term changes in intracellular cAMP levels. HEK293 cells
were seeded at 35,000 cells/well in poly-L-lysine-coated 96-well
plates and transiently transfected the following day with FLAG-
tagged receptor constructs or pcDNA at the indicated concentra-
tions along with the trans-activator plasmid pFA2-CREB and the
reporter plasmid pFRLUC at 6 ng/well and 50 ng/well, respec-
tively. If used, ligands were added 5 h prior to assay start. The
CREB activity was determined 24 h after transfection using the
SteadyLite substrate (Perkin Elmer). Briefly, cells were washed
twice in Dulbecco’s PBS (0.9 mM CaCl2, 2.7 mM KCl, 1.5 mM
KH2PO4, 0.5 mM MgCl2, 137 mM NaCl, and 8.1 mM
Na2HPO4) and the luminescence measured 10 min after addition
of the substrate using a TopCounter. Every receptor construct was
tested at least thrice in quadruples.
Enzyme-Linked Immunosorbent Assay (ELISA)
HEK293 cells were transiently transfected with the indicated
FLAG-tagged receptor constructs as described above. Twenty-four
hours after transfection, the cells were fixed in 4% formaldehyde
for 10 min, washed twice in TBS and blocked for 30 min with
TBS containing 2% BSA. Subsequently, the cells were incubated
with mouse anti-FLAG M1 antibody at 2 mg/ml for 2 h in TBS
supplemented with 1% BSA and 1 mM CaCl2. After three washes
in TBS containing 1 mM CaCl2, the cells were incubated 1 h with
goat anti-mouse horseradish peroxidase-conjugated antibody
diluted 1:1000. Following wash, the immune reactivity was
determined by addition of TMB substrate according to manufac-
turer’s instruction. All steps were carried out at room temperature.
Relative constitutive activity (RCA)
The relative constitutive activity was determined at a gene-dose
of 2.5 ng/well and calculated according to the equations:
CA~
CS
SE
ð1Þ
RCA~
CAmut
CAwt
~
CSmut:SEwt
CSwt:SEmut
ð2Þ
where CA denotes constitutive activity, CS denotes CREB
signaling, SE denotes surface expression (measured by ELISA)
and RCA denotes relative constitutive activity. wt denotes wild
type and mut denotes mutant.
ERK1/2 phosphorylation assay
HEK293 cells were seeded out in 12-well plates and
transfected using the calcium phosphate method with FLAG-
tagged Mc1r wt, Mc1r E92K or pcDNA (1.1 mg/well). The cells
were serum starved overnight and incubated with PBS or aMSH
at 1 mM for 10 min. Subsequently, the cells were washed twice,
lysed in lysis buffer (100 mM Tris, 4% SDS, 20% glycerol and
spun down for 5 min at 1500 rpm and 4uC. The protein
concentration was determined using a BCA protein kit (Pierce).
15-20 mg protein was loaded on Bis-Tris 10% NuPAGE gels and
run for 1.5 h at 140 V followed by blotting onto a ethanol-
activated PVDF membrane for 1.5 h at 30 V. The membrane
was then blocked in TBST (1X TBS with 0.1% Tween20)
containing 5% BSA followed by incubation with rabbit anti-
phopho ERK IgG antibody (1:1000). The membrane was
subsequently incubated in blocking buffer containing goat anti-
rabbit-IgG HRP-conjugated antibody (1:10000) and developed
using SuperSignal West Pico substrate (Pierce). The amount of
phosphorylation was measured using a FlourChem H2A camera.
The membrane was subsequently stripped using Pierce stripping
buffer (Pierce) and the procedure was then repeated with rabbit
anti-ERK IgG antibody to detect total ERK.
Antibody-feeding internalization assay
For the antibody-feeding assays, HEK-g cells (which stably
express the macrophage scavenger receptor) were used as they
adhere better to the surface and are not lost during washing.
HEK-g were seeded on coverslips in 6-well plates at 5?10
5 pr well.
The following day the cells were transfected with FLAG-tagged
Mc1r wt or Mc1r E92K at 150 ng/well using Lipofectamine
TM
2000. Twenty-four hours after transfection, the cells were
incubated in ice-cold DMEM medium containing mouse M1
anti-FLAG antibody at 2 mg/mL and incubated 1 h at 4uC. After
three washes in cold DMEM medium, the specimens were either
immediately fixed in 4% paraformaldehyde or incubated in pre-
warmed DMEM medium containing either vehicle (PBS) or
aMSH (1 mM) at 37uC for 30 min to induce internalization and
then fixed. Subsequently, the coverslips were blocked with TBS
containing 2% BSA. To specifically detect labelled receptors still
residing at the cell surface, the cells were incubated with goat anti-
mouse Alexa Flour 488-conjugated antibody diluted 1:1000 in
TBS containing 1% BSA for 30 min. After washing, the cells were
permeabilized and blocked using TBS containing 1% BSA and
0.2% saponin for 30 min. To detect internalized labelled
receptors, the coverslips were then incubated with goat anti-
mouse Alexa-Fluor 568-conjugated antibodies diluted 1:1000 in
TBS containing 1% BSA for 30 min. Subsequent to washing, the
specimens were mounted in SlowFade Antifade reagent using nail
polish as sealing. All steps following the internalization step were
carried out at room temperature. Mock transfected cells were
included to ensure no unspecific binding of any of the antibodies.
For all images the laser power and channel gains were kept
constant and the slides blinded. For each slide, 10 randomly
chosen cells were examined.
Confocal microscopy
Confocal microscopy was performed using a LSM 510 laser
scanning unit coupled to an inverted microscope with a 63x 1.4
numerical aperture oil immersion Plan-Apochromat objective
(Carl Zeiss). Alexa-Fluor 488 and 586 were excited using an argon-
krypton laser (l = 488 nm) and a He-Ne laser (l = 543 nm),
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averaged over 16 whole frame scans.
ELISA internalization assay
HEK-g cells were seeded at 35,000 cells/well in 96-well plates
and transiently transfected the following day with FLAG-tagged
Mc1r wt, Mc1r E92K or pcDNA at 25 ng/well using Lipofecta-
mine
TM 2000. Twenty-four hours after transfection, the cells were
incubated in cold DMEM containing mouse anti-FLAG M1
antibody at 2 mg/ml for 1 h at 4uC. After three washed in cold
DMEM, the cells were either fixed immediately in 4%
formaldehyde (t=09) or incubated at 37uC in pre-warmed DMEM
containing either vehicle (PBS) or aMSH (1 mM) for 30 min
(t=309) to induce internalization and then fixed. Subsequently, the
cells were blocked for 30 min with PBS containing 2% BSA and
then incubated 1 h with goat anti-mouse horseradish peroxidase-
conjugated antibody diluted 1:1000 in PBS containing 1% BSA.
Following three washes, the immune reactivity was determined by
addition of TMB substrate according to manufacturer’s instruc-
tion. All steps after incubation with primary antibody were carried
out at room temperature. The extent of recycling was estimated by
stripping receptors still residing on the cell surface after 30 min of
incubation and measuring the emergence of tagged receptors
within an hour. After 30 min of incubation approximately 5% of
the tagged receptor pool had been recycled.
b-arrestin recruitment assay
Ligand-induced and constitutive recruitment of b-arrestin by
Mc1R was studied using the PathHunter b-Arrestin Assay
(DiscoveRx) which utilizes an enzyme fragment complementation
technology. cDNA for the Mc1r wt and mutants (E92A, E92K)
was C-terminally fused with a ProLink tag (DiscoveRx) encoding
accessory linker and the small fragment of b-galactosidase (b-gal)
and cloned into the pcDNA3.1(+) vector. Assays were performed
in a CHO-K1 EA-arrestin parental cell line (DiscoveRx) stably
expressing b-arrestin fused with b-gal inactive fragment. Cells
were transfected using FuGENE6 transfection reagent according
to manufacturer’s protocol. Briefly, one day prior to transfection,
cells were seeded out in white 96-well plates at a density of 20 000
cells/well. Culture medium was exchanged with OptiMEM I
reduced serum medium (50 mL/well). DNA:transfection-reagent
complexes were prepared by diluting 0.15 ml FuGENE6 reagent
and 50 ng DNA in 50 ml OptiMEM I reduced serum medium (all
values given for a single well) and added to cells after 15 min
incubation at ambient temperature. Cells were incubated
overnight followed by replacement of the OptiMEM I medium
with assay medium (culture medium without antibiotics). The b-
arrestin recruitment assay was performed 48 hours after transfec-
tion. Cells were stimulated with range of concentrations of a-MSH
for 90 min. Upon b-arrestin binding to ProLink-tagged Mc1r,
complementation occurs between the b-gal fragments forming an
active enzyme. Thus, b-arrestin recruitment to the receptors was
detected as b-gal activity using the PathHunter detection kit
(DiscoveRx). Luminescence signal was measured 60 min after
addition of chemiluminescent substrate using a TopCounter.
Competition binding assay
HEK293 cells were seeded out in 24-well plates at a
concentration that obtained 10% specific binding of the added
radioligand, [
125I]-NDP-MSH (Perkin Elmer). For Mc1r wt and
the E92K mutant, cells were seeded out at 15,000 cells/well
whereas 50,000 cells/well were used for the E92A mutant. The
cells were transfected using Lipofectamine2000 and 50 ng DNA/
well. One day after transfection, cells were assayed by competition
binding for 3 h at 4uC using varying concentrations of unlabelled
a-MSH and 60–70 pM [
125I]-NDP-MSH in 50 mm Hepes buffer
pH 7.4, supplemented with 1 mm CaCl2, 5 mm MgCl2, and 0.5%
(w/v) bovine serum albumin. After incubation, cells were washed
two times in 4 uC binding buffer supplemented with 0.5 m NaCl.
After addition of lysis buffer, the amount of binding was measured
using a c-radiation counter (Wallac). Nonspecific binding was
determined as the binding in the presence of 1 mM unlabeled a-
MSH. Determinations were made in duplicates.
Supporting Information
Figure S1 Gene-dosing of Mc1r wt and Mc1r E92K. A–B.
CREB activity (A) and cell surface expression (B) in HEK293 cells
transiently transfected with 11 gene-doses ranging from 0 to 5 ng
DNA per well of Mc1r wt (solid squares) or Mc1r E92K (open
squares) and CREB-LUC reporter vector. The results are
presented as mean 6 SEM of background-corrected (pcDNA-
transfected cells) data of three independent experiments performed
in quadruples. The stapled line indicates the 2.5 ng DNA per well
gene-dose chosen for RCA value calculation. C. Correlation of
data from A and B normalized to the CREB activity and cell
surface expression values of Mc1r wt at 5 ng DNA per well in
percent.
(TIF)
Figure S2 ECL1 chimera of human MC1R. A. CREB
activity (left panel) and cell surface expression (middle panel) in
HEK293 cells transiently transfected with human MC1R wt (solid
squares) or human MC1R E94K (open squares). The results are
given relative to the value at 0 ng DNA per well as mean 6 SEM
of background-corrected (pcDNA-transfected cells) data of two
independent experiments performed in quadruples. The RCA
value is given to the right and is presented relative to the RCA of
human MC1R wt in percent as mean 6 SEM. B. CREB activity
(left panel) and cell surface expression (middle panel) in HEK293
cells transiently transfected with mMC4R-Mc1r ECL1 wt (solid
squares) or E94K (open squares) chimeras and CREB-LUC
reporter vector. The results as well as the RCA value (right) are
presented as in A. The serpentine insert in A indicate the position
of E94 (black) whereas it in B indicates the hMC4R ECL1 (black)
substituted into human MC1R (white). * p,0.05.
(TIF)
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